Is Daicel Corporation profitable in 2026?

Yes. For fiscal year ended March 2025, Daicel reported net sales of ¥586.5bn and net profit attributable to owners of ¥49.5bn, up from ¥19.7bn in FY2021/3. Operating income was ¥61.0bn and EBITDA ¥102.4bn, per Daicel's own financial results filing.

Could AI replace Daicel's business?

No. Daicel's core moat is physical chemistry manufacturing and decades-long automotive OEM safety certification for airbag inflators and engineering plastics. Daicel uses AI internally only as a tool, via Materials Informatics for material design, not as a replacement for its certified plants or propellant IP.

Who is Daicel's biggest competitor in airbag inflators?

Autoliv is the largest global airbag inflator supplier, holding roughly 43% market share as of 2025 according to industry research firm GMInsights. Daicel competes alongside ZF, Joyson Safety Systems (Takata's successor), Toyoda Gosei and Nippon Kayaku in a stable oligopoly.

Does Daicel still make rocket propellants or military products?

No. Daicel formally completed its withdrawal from the defense-related business, including rocket motors for military use, by the end of March 2023, per DAICEL REPORT 2023. Its pyrotechnic chemistry today is applied to civilian automotive airbags, seatbelt pretensioners and Pyro-Fuse EV disconnects.

What is Daicel's biggest growth market right now?

Engineering plastics and automotive safety are Daicel's stated growth drivers. Its Polyplastics subsidiary holds the global number one share in liquid crystal polymer (LCP) and a top share in POM, and Daicel launched a new wearable airbag business in May 2026 targeting 2027 commercialization.

Has Daicel been involved in the Takata airbag scandal?

Daicel is a separate manufacturer from the bankrupt Takata Corporation, whose assets were absorbed by Joyson Safety Systems after a 2017 collapse. Takata-related litigation continues, with automaker settlements exceeding $1.5 billion as of December 2025, keeping sector-wide inflator scrutiny elevated for all suppliers including Daicel.

Space, defense and state enterprises · Japan

Daicel Corporation

daicel.com ↗

Japanese chemicals maker: airbag inflators, LCP/POM plastics, cellulose acetate.

Hard to displace

Assessed 30 July 2026 · Evidence as of 30 July 2026

Strong structural protection; the business model survives ai pressure.

On the recordSince 30 July 2026 · Checkable from May 2026 · Every call on the record Checkpoint: FY2026/3 full-year results and 'Accelerate 2030' progress update

The call

A century-old chemicals group growing steadily on airbag inflators and engineering plastics, with safety incidents and Autoliv's scale as the main things worth watching.

Daicel makes chemical products used in car airbags, specialty plastics for electronics and cars, and other industrial materials. It is hard to replace in airbags because car makers take years to qualify new suppliers and Daicel has deep expertise in the chemistry involved, though its main rival Autoliv is stable and not aggressively taking its business. The biggest risk is that safety problems in the airbag industry (like the Takata scandal years ago and recent recalls) could trigger regulators to demand changes Daicel cannot meet, or that a defect in Daicel's own products could cause car makers to switch suppliers.

Why

AI pressure: None apparent. Airbag pyrotechnics and polymer chemistry sit on physical plants and OEM approvals, not code, so generative AI has no obvious opening here. Could AI do the core job? Unlikely.

Bigger players: Autoliv. Autoliv already holds roughly 43% of the global inflator market and competes head to head for the same OEM contracts. Could a giant copy it? No, they are blocked.

What protects it. Tier-1 automakers requalify inflator suppliers slowly, and Polyplastics' global #1 LCP position is hard to replicate quickly.

What would change this call

Any NHTSA or JAMA recall naming Daicel inflators specifically (not just Autoliv/other suppliers) within 12 months. Would show Daicel's OEM qualification moat eroding, not just industry-wide scrutiny.
Daicel's FY2026/3 results (due ~May 2026) versus Accelerate 2030 targets. Would show whether portfolio rotation and margin recovery are on track or stalling.
Regulatory or legal findings from the May 2025 Aboshi Plant fatal incident investigation. Would show whether compliance costs or safety trust damage extend beyond a one-off event.

Key numbers

FY2025/3 net sales ¥586.5bn, up 5.1% YoY (2025-03-31)
FY2025/3 operating income ¥61.0bn, down 2.2% (2025-03-31)
Overseas sales 67.3% of total revenue (2025-03-31)

Named risks

Fatal incident at Aboshi Plant (May 2025) raises safety and compliance follow-up exposure. Severity: high
Sector-wide Takata litigation and NHTSA inflator recalls (Kia Aug 2025, Nissan/Infiniti Jan 2025) keep regulatory scrutiny elevated. Severity: medium
Secular decline in cellulose acetate tow demand for cigarette filters pressures Materials segment. Severity: medium
2027 wearable airbag commercialization depends on ongoing clinical research with Hiroshima University Hospital. Severity: low
ROIC of only 6.1% in FY2025/3 signals modest capital efficiency versus diversified conglomerate scale. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
Autoliv	contesting	Autoliv holds ~43% of global airbag inflator market share as of 2025 per GMInsights industry report
Joyson Safety Systems (Takata successor)	contesting	Competes in inflator supply amid ongoing Takata litigation exceeding $1.5bn in settlements as of Dec 2025
ZF Friedrichshafen	contesting	Ranked among top global airbag inflator suppliers alongside Daicel per 2026 industry reporting
Celanese and Mitsubishi Engineering-Plastics	gaining on	Daicel's Polyplastics subsidiary holds global #1 share in LCP and top share in POM as of FY2025/3

Questions people ask

Is Daicel Corporation profitable in 2026?: Yes. For fiscal year ended March 2025, Daicel reported net sales of ¥586.5bn and net profit attributable to owners of ¥49.5bn, up from ¥19.7bn in FY2021/3. Operating income was ¥61.0bn and EBITDA ¥102.4bn, per Daicel's own financial results filing.
Could AI replace Daicel's business?: No. Daicel's core moat is physical chemistry manufacturing and decades-long automotive OEM safety certification for airbag inflators and engineering plastics. Daicel uses AI internally only as a tool, via Materials Informatics for material design, not as a replacement for its certified plants or propellant IP.
Who is Daicel's biggest competitor in airbag inflators?: Autoliv is the largest global airbag inflator supplier, holding roughly 43% market share as of 2025 according to industry research firm GMInsights. Daicel competes alongside ZF, Joyson Safety Systems (Takata's successor), Toyoda Gosei and Nippon Kayaku in a stable oligopoly.
Does Daicel still make rocket propellants or military products?: No. Daicel formally completed its withdrawal from the defense-related business, including rocket motors for military use, by the end of March 2023, per DAICEL REPORT 2023. Its pyrotechnic chemistry today is applied to civilian automotive airbags, seatbelt pretensioners and Pyro-Fuse EV disconnects.
What is Daicel's biggest growth market right now?: Engineering plastics and automotive safety are Daicel's stated growth drivers. Its Polyplastics subsidiary holds the global number one share in liquid crystal polymer (LCP) and a top share in POM, and Daicel launched a new wearable airbag business in May 2026 targeting 2027 commercialization.
Has Daicel been involved in the Takata airbag scandal?: Daicel is a separate manufacturer from the bankrupt Takata Corporation, whose assets were absorbed by Joyson Safety Systems after a 2017 collapse. Takata-related litigation continues, with automaker settlements exceeding $1.5 billion as of December 2025, keeping sector-wide inflator scrutiny elevated for all suppliers including Daicel.

Timeline

2026-05-24Daicel launches wearable airbag business, targets 2027 commercial launch with Hiroshima University Hospital
2026-03Daicel agrees to sell 15% stake in Toyo Styrene to Denka Company
2026-01Polyplastics-Evonik announces plan to rename itself Daicel-Evonik Corporation
2025-11Daicel secures PMDA approval for needle-free injector Daicel Injector P1 SC in Japan
2025-05Fatal incident occurs at Daicel's Aboshi Plant
2024-07-01Daicel transfers ABS resin and polymer alloy business to new affiliate Novacel Co., Ltd.
2023-10Daicel founds Daicel Medical Ltd.
2023-03Daicel completes withdrawal from defense-related rocket motor business and divests pharma unit Lomapharm
2020-10Daicel makes Polyplastics Co., Ltd. a wholly owned subsidiary

Revision history

30 July 2026

First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.

In the same band

Kongsberg Gruppen Teledyne Technologies Aselsan

More in Space, defense and state enterprises →

Sources